Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000904545 | SCV001049067 | benign | Nemaline myopathy 2 | 2024-01-08 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000904545 | SCV001457259 | uncertain significance | Nemaline myopathy 2 | 2020-01-24 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004551741 | SCV004732589 | likely benign | NEB-related disorder | 2022-07-06 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |